吴克美, 张曼云, 方正, 黄量. 抗白血病药物靛玉红的N1′-取代物的合成J. 药学学报, 1984, 19(7): 513-518.
引用本文: 吴克美, 张曼云, 方正, 黄量. 抗白血病药物靛玉红的N1′-取代物的合成J. 药学学报, 1984, 19(7): 513-518.
WU Ke-Mei, ZHANG Man-Yun, FANG Zheng , HUANG Liang, . SYNTHESIS OF N1′-SUBSTITUTED DERIVATIVES OF INDIRUBIN, AN ANTILEUKEMIC COMPOUNDJ. Acta Pharmaceutica Sinica, 1984, 19(7): 513-518.
Citation: WU Ke-Mei, ZHANG Man-Yun, FANG Zheng , HUANG Liang, . SYNTHESIS OF N1′-SUBSTITUTED DERIVATIVES OF INDIRUBIN, AN ANTILEUKEMIC COMPOUNDJ. Acta Pharmaceutica Sinica, 1984, 19(7): 513-518.

抗白血病药物靛玉红的N1′-取代物的合成

SYNTHESIS OF N1′-SUBSTITUTED DERIVATIVES OF INDIRUBIN, AN ANTILEUKEMIC COMPOUND

  • 摘要: 为提高靛玉红在体内的吸收及其治疗白血病的疗效,从增加化合物的溶解度着手,设计合成了16个N1′,-取代的靛玉红衍生物。N1′,的取代增加了化合物的脂溶性。4个衍生物(Ⅲ,Ⅳ,Ⅻ和ⅩⅤ)对大鼠瓦氏癌肉瘤的抑制率在与靛玉红等克分子剂量下较母体的高。在同一实验中化合物Ⅲ的抑制率为58%,而靛玉红为30.8%。

     

    Abstract: Indirubin isolated from Indigofera tictoria L. (青黛) is an active constituent against chronic granulocytic leukemia, Sixteen N1'-substituted derivatives of indirubin were synthesized in an attempt to reduce the toxicity and raise the antitumor activity.The phase transfer catalyzed reaction was adopted for preparation of N1'-substituted derivatives (Ⅱ~ⅩⅢ, ⅩⅤ~ⅩⅦ), except compound ⅩⅣ which was obtained by condensation of N-formylisatin with potassium indoxylate.Compound Ⅲ, Ⅳ, Ⅶ, ⅩⅤ showed higher inhibitory action against Carcinoma W256 in rats than indirubin on equal molar basis. Compound Ⅲ is the most potent compound with inhibitory activity of 58%, compared with 30.8% of indirubin in the same experiment.

     

/

返回文章
返回